Stroke Treatment with rtPA – Are There any Contraindications?

Bibliografische Angaben

Nachweis in CareLit

Kernaussage aus der Literatur

Abstract-Vorschau

In the last two decades therapy with recombinant tissue plasminogen activator has been proved the only treatment option in acute ischemic stroke. However, despite unequivocal evidence of patient's benefit from randomized trials and implementation of thrombolytic therapy in national and international guidelines, the transmission into clinical practice is poor. Only a minority of patients receive thrombolysis with sev…

Zitieren

Zitierempfehlung

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur